NRC draft guidance may complicate patient access to cancer treatment

August 18, 2023, 8:53AMNuclear News

A Nuclear Regulatory Commission draft regulatory guide—DG-8061, “Release of Patients Administered Radioactive Material”—proposes guidance on the release of patients after a medical procedure involving the administration of radiopharmaceuticals or the implantation of a sealed source. The guidance is intended to help licensees interpret NRC regulations designed to protect the people—family, friends, caregivers, or members of the general public—who may be in proximity to a patient who is discharged after receiving nuclear medicine treatment.

To continue reading, log in or create a free account!

Related Articles

NRC approves NuScale uprated SMR design

June 2, 2025, 9:30AMNuclear News

NuScale earned approval for its “larger” US460 77-MWe small modular reactor plant design, the Nuclear Regulatory Commission announced last week.The standard design approval (SDA) is a...

NRC news roundup

Summer progress; Waterford news; safety report of Northeast plants

May 16, 2025, 9:30AMNuclear News

Here’s a look at some recent announcements from the Nuclear Regulatory Commission.Summer SLR: The NRC this month published its final environmental impact statement for Summer Unit 1’s...